Author:
Panda Bijan Kumar,Jena Parsuram,Jena Dhaneswari
Abstract
Background: Hypertension affects a significant number of population and many of these affected individuals have no symptoms. The present study was conducted to assess effects of antihypertensive agents on the quality of life in diabetic hypertensive patients. Materials & Methods: 96 diabetic hypertensive patients of both genders were randomly divided into 4 groups based on antihypertensive medicines- group I comprises those taking amlodipine (2.5–10 mg/day), group II taking ramipril (2.5–10 mg/day), group III taking telmisartan (40–80 mg/day) and group IV taking combination of ramipril (1.25–5 mg/day) and telmisartan (20–40 mg/day) (RT). Parameters such as blood pressure (BP), pulse rate, blood sugar level, glycated hemoglobin (HbA1c) and QOLID-Punjabi version (PV) questionnaire at baseline and then at the 24th week of therapy. QoL of the patients was assessed by using the QOLID questionnaire Results: Group I had 12 males and 12 females, group II had 14 males and 10 females, group III had 15 males and 9 females and group IV had 10 males and 14 females.
Publisher
Universidad Tecnica de Manabi
Subject
Education,General Nursing
Reference13 articles.
1. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, et al. Effect of ramipril vs. amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial. JAMA 2001;285:2719-28.
2. Redon J, Mancia G, Sleight P, Schumacher H, Gao P, Pogue J, et al. Safety and efficacy of low blood pressures among patients with diabetes: Subgroup analyses from the ONTARGET (Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). J Am Coll Cardiol 2012;59:74-83.
3. Gadge P, Gadge R, Paralkar N, Jain P, Tanna V. Effect of telmisartan on blood pressure in patients of type 2 diabetes with or without complications. Perspect Clin Res 2018;9:155-60.
4. Delles C, Raff U, Mimran A, Fauvel JP, Ruilope LM, Schmieder RE. Effects of telmisartan and ramipril on adiponectin and blood pressure in patients with type 2 diabetes. Am J Hypertens 2008;21:1330-6.
5. Morimoto S, Yano Y, Maki K, Sawada K. Renal and vascular protective effects of telmisartan in patients with essential hypertension. Hypertens Res 2006;29:567-72.